Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-11

Clinical Trial Update: Study of Silodosin to Facilitate Passage of Urinary Stones [Phase 2]

View source ↗

Summary

Phase 2 study of silodosin to facilitate passage of urinary stones has completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rapaflo (silodosin)

Snippet

Sponsor: Watson Pharmaceuticals | Conditions: Ureteral Calculi, Kidney Stones | Phase 2 | Status: COMPLETED | Results posted: 2014-08-11